1.Maternal mobile phone screen time during pregnancy and children's internalizing and externalizing behavioral problems.
Han LI ; Juan TONG ; Fang Biao TAO
Chinese Journal of Preventive Medicine 2023;57(12):2196-2200
The behavioral problems of children and adolescents are becoming more and more serious, and the prevalence rate is increasing year by year. The overall trend is increasing, which has become one of the important public health issues of global concern. There are many influencing factors for behavioral problems in children and adolescents, including genetic, psychosocial, family and early life environment. Among them, maternal screen exposure during pregnancy is a contributing factor that deserves attention and has practical intervention significance. This study systematically evaluated the association between maternal mobile phone screen time during pregnancy and children's internalizing and externalizing behavioral problems, its potential biological mechanisms and relevant intervention measures, in order to create a good intrauterine environment for fetal neurodevelopment and further reduce the occurrence of children's behavioral problems.
Adolescent
;
Child
;
Female
;
Pregnancy
;
Humans
;
Problem Behavior
;
Screen Time
;
Cell Phone
;
Family
;
Maternal Exposure
2.Maternal mobile phone screen time during pregnancy and children's internalizing and externalizing behavioral problems.
Han LI ; Juan TONG ; Fang Biao TAO
Chinese Journal of Preventive Medicine 2023;57(12):2196-2200
The behavioral problems of children and adolescents are becoming more and more serious, and the prevalence rate is increasing year by year. The overall trend is increasing, which has become one of the important public health issues of global concern. There are many influencing factors for behavioral problems in children and adolescents, including genetic, psychosocial, family and early life environment. Among them, maternal screen exposure during pregnancy is a contributing factor that deserves attention and has practical intervention significance. This study systematically evaluated the association between maternal mobile phone screen time during pregnancy and children's internalizing and externalizing behavioral problems, its potential biological mechanisms and relevant intervention measures, in order to create a good intrauterine environment for fetal neurodevelopment and further reduce the occurrence of children's behavioral problems.
Adolescent
;
Child
;
Female
;
Pregnancy
;
Humans
;
Problem Behavior
;
Screen Time
;
Cell Phone
;
Family
;
Maternal Exposure
3.Prenatal diagnosis of partial deletion of NRXN1 gene with combined CNV-seq and qPCR assays.
Lixia WANG ; Panlai SHI ; Hua'nan REN ; Shuyuan XUE ; Xiangdong KONG
Chinese Journal of Medical Genetics 2022;39(11):1200-1204
OBJECTIVE:
To summarize the genetic diagnosis, low-depth copy number variation sequencing (CNV-seq) and prenatal finding in 7 fetuses with 2p16.3 deletions only involving the NRXN1 gene.
METHODS:
The 7 fetuses have all been found to have loss of heterozygosity at 2p16.3 by CNV-seq, which were verified by quantitative real-time PCR (qPCR). Specific regions of NRXN1 gene deletions were identified, and the CNVs were verified in their parents. Outcome of the pregnancies were followed up.
RESULTS:
Among 16 502 prenatal samples, 7 fetuses were found to harbor a 120 kb ~ 900 kb microdeletion in the 2p16.3 region, which yielded a prevalence of 0.424‰. The deleted region mainly involved 50 200 000-51 880 000 positions of chromosome 2 and involved only the NRXN1 gene. All of the 7 fetal CNVs were confirmed by qPCR, including 2 cases with heterozygous deletion of exons 1 to 6, 1 with heterozygous deletion of exons 1 to 19, 1 with heterozygous deletion of exons 19 to 22, and 3 with heterozygous deletion of introns 6 to 7 of the NRXN1 gene. Verification in the parents had found that one deletion was inherited from the father, 1 was from the mother, 2 cases were de novo in origin, whilst the remaining 3 had refused parental verification. After genetic counseling, one couple had elected induced abortion, 1 case has not been born yet, whilst the other 5 cases were born healthy. Follow up had identified no mental abnormalities among the children.
CONCLUSION
Seven fetuses with heterozygous 2p16.3 deletions only involving the NRXN1 gene were detected by CNV-seq. The specific deletion of the NRXN1 gene was verified by qPCR. Prenatal genetic counseling and fertility guidance has been provided to the particular family by combining the results of CNV testing, pedigree analysis and pregnancy outcome.
Female
;
Humans
;
Pregnancy
;
Calcium-Binding Proteins/genetics*
;
Cell Adhesion Molecules, Neuronal/genetics*
;
DNA Copy Number Variations
;
Nerve Tissue Proteins/genetics*
;
Neural Cell Adhesion Molecules/genetics*
;
Prenatal Diagnosis
;
Real-Time Polymerase Chain Reaction
;
Infant, Newborn
4.A time-motion study on the operating room processes among pregnant COVID-19 patients undergoing cesarean section in a tertiary government hospital
Ma. Evita D. dela Cruz-Tabanda ; Maria Angela R. Bandola
Acta Medica Philippina 2021;55(2):224-230
Objective. This study aims to determine time and motion in the operating room in emergent, urgent and scheduled cesarean section surgeries among pregnant COVID-19 patients.
Methodology. A time and motion performance evaluation study was done by computing the following parameters: pre-induction time, pre-incision time, opening time, closing time, for both decision-to-delivery interval (DDI) and overall operative time.
Results. During the study period, emergent DDI average was 2 hours and 38 minutes, emergent overall operative time was 1 hour and 31 minutes, urgent DDI average was 3 hours and 51 minutes, and urgent overall operative time of 1 hour and 57 minutes. However, in both urgent and emergent cases, the recommended DDI of 30 minutes, and the average duration of 44.3 minutes for CS were not feasible.
Conclusion. The COVID-19 pandemic has negatively affected the provision of surgical obstetric care and OR utilization. Due to the new safety protocol for healthcare workers and patients, there was a significant delay in DDI and overall operative time. The causes were preparation, anesthesia factors or obstetrician factors. Identifying modifiable obstacles may improve the DDI, overall operative time, and the quality of maternal and child birth care during this pandemic.
Pregnancy
;
Female
;
Cesarean Section
;
Time and Motion Studies
;
COVID-19
;
Time Perception
;
Motion
6.Surgical treatment of tubal ectopic pregnancy through posterior colpotomy: experience from a Brazilian university hospital
Tábata Longo da Silva MACHADO ; Alysson ZANATTA ; Larissa Gonçalves Braz SANTOS ; Rafaella Ferreira de Araújo LITVIN ; Lizandra Moura Paravidine SASAKI ; Júlio ELITO JÚNIOR ; Edward ARAUJO JÚNIOR ; Alberto Moreno ZACONETA
Obstetrics & Gynecology Science 2019;62(6):487-490
The objective of this study was to evaluate the feasibility of posterior colpotomy for the surgical treatment of tubal ectopic pregnancy in hemodynamically stable women. We performed a retrospective analysis of medical records obtained over a period of 18 months. Twelve cases were identified, with the following characteristics: mean gestational age, 7.7 weeks; mean serum β-human chorionic gonadotropin level, 7,786 mIU/mL; and greater diameter of the mass, 15–69 mm. Treatment was successful in all cases. Salpingectomy was performed in 10 patients (83.3%) and salpingostomy, in 1 patient. The remaining patient only received peritoneal lavage, as the evidence of ectopic abortion with only a slightly dilated uterine tube was found during surgery. The mean surgical time was 42.5 minutes. In the analyzed cases, posterior colpotomy was found to be a feasible alternative method for the surgical treatment of tubal ectopic pregnancy in hemodynamically stable women.
Chorionic Gonadotropin
;
Colpotomy
;
Fallopian Tubes
;
Female
;
Gestational Age
;
Humans
;
Medical Records
;
Methods
;
Operative Time
;
Peritoneal Lavage
;
Pregnancy
;
Pregnancy, Ectopic
;
Pregnancy, Tubal
;
Retrospective Studies
;
Salpingectomy
;
Salpingostomy
;
Surgical Procedures, Operative
7.Effect of Birth Experience on Cognitive Function
Hyun Jun KIM ; Joonsup SONG ; Hyun Kyung PARK ; Nam Mi KANG ; Jin Ju JUNG ; Min Ji KIM ; Soon Cheol CHUNG ; Mi Hyun CHOI
Journal of the Korean Society of Maternal and Child Health 2019;23(2):109-114
PURPOSE: This study aimed to investigate whether birth experience affects short-term memory (1,2-back task) by examining parturient and non-parturient women. METHODS: A total of 31 women were enrolled in this study, of which 16 were parturient women who had given birth within the past 2 years (mean age: 33.9±2.2 years) and 15 were non-parturient (mean age: 31.4±2.1 years). The mean age did not significantly differ between the two groups, so the effects of age were eliminated. To match the level of education between the two groups, college graduation was an inclusion criterion. A 1,2-back task consisting of six alphabets from A–F was created using the SuperLab software. For each task, there were 100 stimuli (alphabets) and 30 answers. The participants practiced the task prior to the main experiment to ensure that they adequately understood the procedure. RESULTS: The correct answer rates in the 1-back and 2-back tasks were 93.56±22.23% and 76.89±21.98%, respectively, in the non-parturient group and 95±10.04% and 80.83±13.67%, respectively, in the parturient group. The reaction time in the 1-back and 2-back tasks were 650.57±173.77 ms and 736.77±138.35 ms, respectively, in the non-parturient group and 621.91±81.90 ms and 737.5±195.99 ms, respectively, in the parturient group. There were no significant differences in the answer rates between the two groups, suggesting that parturition did not have a significant impact on the 1,2-back task performance. CONCLUSION: Birth experience does not significantly impair cognitive function. However, the findings of this pilot study are not highly reliable because of the limitations of the small sample size, degree of load, various types of working memory, and impact of hormones.
Cognition
;
Education
;
Female
;
Humans
;
Memory, Short-Term
;
Parturition
;
Pilot Projects
;
Pregnancy
;
Reaction Time
;
Sample Size
;
Task Performance and Analysis
8.Clinical Phenotype of a First Unprovoked Acute Pulmonary Embolism Associated with Antiphospholipid Antibody Syndrome.
Yong Sub NA ; Seongsoo JANG ; Seokchan HONG ; Yeon Mok OH ; Sang Do LEE ; Jae Seung LEE
Tuberculosis and Respiratory Diseases 2019;82(1):53-61
BACKGROUND: Antiphospholipid antibody syndrome (APS), an important cause of acquired thrombophilia, is diagnosed when vascular thrombosis or pregnancy morbidity occurs with persistently positive antiphospholipid antibodies (aPL). APS is a risk factor for unprovoked recurrence of pulmonary embolism (PE). Performing laboratory testing for aPL after a first unprovoked acute PE is controversial. We investigated if a specific phenotype existed in patients with unprovoked with acute PE, suggesting the need to evaluate them for APS. METHODS: We retrospectively reviewed patients with PE and APS (n=24) and those with unprovoked PE with aPL negative (n=44), evaluated 2006–2016 at the Asan Medical Center. We compared patient demographics, clinical manifestations, laboratory findings, and radiological findings between the groups. RESULTS: On multivariate logistic regression analysis, two models of independent risk factors for APS-PE were suggested. Model I included hemoptysis (odds ratio [OR], 12.897; 95% confidence interval [CI], 1.025–162.343), low PE severity index (OR, 0.948; 95% CI, 0.917–0.979), and activated partial thromboplastin time (aPTT; OR, 1.166; 95% CI, 1.040–1.307). Model II included age (OR, 0.930; 95% CI, 0.893–0.969) and aPTT (OR, 1.104; 95% CI, 1.000–1.217). CONCLUSION: We conclude that patients with first unprovoked PE with hemoptysis and are age <40; have a low pulmonary embolism severity index, especially in risk class I–II; and/or prolonged aPTT (above 75th percentile of the reference interval), should be suspected of having APS, and undergo laboratory testing for aPL.
Antibodies, Antiphospholipid*
;
Antiphospholipid Syndrome*
;
Chungcheongnam-do
;
Demography
;
Hemoptysis
;
Humans
;
Logistic Models
;
Partial Thromboplastin Time
;
Phenotype*
;
Pregnancy
;
Pulmonary Embolism*
;
Recurrence
;
Retrospective Studies
;
Risk Factors
;
Thrombophilia
;
Thrombosis
9.A pilot study of gonadotropin-releasing hormone agonist combined with aromatase inhibitor as fertility-sparing treatment in obese patients with endometrial cancer
Zhibo ZHANG ; Huifang HUANG ; Fengzhi FENG ; Jinhui WANG ; Ninghai CHENG
Journal of Gynecologic Oncology 2019;30(4):e61-
OBJECTIVE: This study aims to evaluate the effects and pregnancy outcomes of gonadotropin-releasing hormone agonist (GnRH agonist) combined with aromatase inhibitor (AI) in preserving the fertility of obese women with grade 1 endometrial cancer (EC). METHODS: This study recruited obese EC patients who wished to preserve their fertility. The treatment regimen consisted of intramuscular GnRH agonist 3.75 mg every 4 weeks and oral AI 2.5 mg daily. The maintenance regimen was the same as the initial treatment regimen. Primary outcomes included response rate, time to complete response (CR), and time to recurrence; pregnancy outcomes included the time to pregnancy, pregnancy rate and live birth rate. RESULTS: Six obese patients with EC were included in this study, with the age (mean±standard deviation [SD]) of 30.5±3.3 years and body mass index (mean±SD) of 35.0±1.4 kg/m2. CR rate was 100%, and time to CR was 3–6 months. None of the patients had recurrence after a median follow-up of 4.0 years (range, 1.3–7.0 years). The most common side effects were menopause-like symptoms. Among these patients, no weight gain was observed during treatment. The pregnancy rate and live birth rate was 50.0% and 75.0%, respectively, with a median time to pregnancy of 2.4 years (range, 1.0–5.5 years). CONCLUSION: The combination of GnRH agonist and AI demonstrated promising long-term effect in young obese EC patients who wished to preserve their fertility. No weight gain side effects were observed. Further studies with a larger sample size are needed to fully evaluate this novel treatment regimen.
Aromatase Inhibitors
;
Aromatase
;
Body Mass Index
;
Endometrial Neoplasms
;
Female
;
Fertility
;
Follow-Up Studies
;
Gonadotropin-Releasing Hormone
;
Humans
;
Live Birth
;
Obesity
;
Organ Sparing Treatments
;
Pilot Projects
;
Pregnancy
;
Pregnancy Outcome
;
Pregnancy Rate
;
Recurrence
;
Sample Size
;
Time-to-Pregnancy
;
Weight Gain
10.Coagulation abnormalities and bleeding in pregnancy: an anesthesiologist's perspective
Anesthesia and Pain Medicine 2019;14(4):371-379
During pregnancy, the procoagulant activity increases (manifested by elevation in factor VII, factor VIII, factor X, and fibrinogen levels), while the anticoagulant activity decreases (characterized by reduction in fibrinolysis and protein S activity), resulting in hypercoagulation. Standard coagulation tests, such as prothrombin time or activated partial thromboplastin time, are still used despite the lack of evidence supporting its accuracy in evaluating the coagulation status of pregnant women. Thromboelastography and rotational thromboelastometry, which are used to assess the function of platelets, soluble coagulation factors, fibrinogen, and fibrinolysis, can replace standard coagulation tests. Platelet count and function and the effect of anticoagulant treatment should be assessed to determine the risk of hematoma associated with regional anesthesia. Moreover, anesthesiologists should monitor patients for postpartum hemorrhage (PPH), and attention should be paid when performing rapid coagulation tests, transfusions, and prohemostatic pharmacotherapy. Transfusion of a high ratio of plasma and platelets to red blood cells (RBCs) showed high hemostasis success and low bleeding-related mortality rates in patients with severe trauma. However, the effects of high ratios of plasma and platelets and the ratio of plasma to RBCs and platelets to RBCs in the treatment of massive PPH were not established. Intravenous tranexamic acid should be administered immediately after the onset of postpartum bleeding. Pre-emptive treatment with fibrinogen for PPH is not effective in reducing bleeding. If fibrinogen levels of less than 2 g/L are identified, 2–4 g of fibrinogen or 5–10 ml/kg cryoprecipitate should be administered.
Anesthesia, Conduction
;
Blood Coagulation Factors
;
Blood Transfusion
;
Drug Therapy
;
Erythrocytes
;
Factor VII
;
Factor VIII
;
Factor X
;
Female
;
Fibrinogen
;
Fibrinolysis
;
Hematoma
;
Hemorrhage
;
Hemostasis
;
Humans
;
Mortality
;
Partial Thromboplastin Time
;
Plasma
;
Platelet Count
;
Postpartum Hemorrhage
;
Postpartum Period
;
Pregnancy
;
Pregnant Women
;
Protein S
;
Prothrombin Time
;
Thrombelastography
;
Tranexamic Acid


Result Analysis
Print
Save
E-mail